NCT07415005 2026-02-17
Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
Clinical Trials
3 trialsNCT05676931 2025-10-02
EDGE-Lung
Gilead Sciences
Phase 2 Active not recruiting
NCT05557591 2025-08-21
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
Regeneron Pharmaceuticals
Phase 2 Active not recruiting